Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Other financing activities (2021 - 2025)

Lexaria Bioscience's Other financing activities history spans 3 years, with the latest figure at $167219.0 for Q1 2025.

  • For Q1 2025, Other financing activities changed N/A year-over-year to $167219.0; the TTM value through Feb 2025 reached $1.2 million, changed N/A, while the annual FY2021 figure was $85000.0, N/A changed from the prior year.
  • Other financing activities for Q1 2025 was $167219.0 at Lexaria Bioscience, up from -$300000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.2 million in Q1 2022 and bottomed at -$300000.0 in Q2 2022.
  • The 3-year median for Other financing activities is $126109.5 (2021), against an average of $288054.8.